Erlotinib in salvage treatment of patients with advanced non-small cell lung cancer: results of an expanded access programme in Poland

Współczesna Onkologia ◽

10.5114/wo.2012.28798 ◽

2012 ◽

Vol 2 ◽

pp. 170-175

Author(s):

Dariusz M. Kowalski ◽

Maciej Krzakowski ◽

Rodryg Ramlau ◽

Piotr Jaskiewicz ◽

Anna Janowicz-Żebrowska

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Salvage Treatment ◽

Small Cell ◽

Small Cell Lung ◽

Expanded Access ◽

Expanded Access Programme ◽

Access Programme

Download Full-text

Efficacy and safety of nivolumab in elderly patients (pts) with advanced squamous non small cell lung cancer (Sq-NSCLC) participating in the expanded access programme (EAP) in Italy

Annals of Oncology ◽

10.1093/annonc/mdw378.33 ◽

2016 ◽

Vol 27 ◽

pp. vi369 ◽

Cited By ~ 2

Author(s):

F. Grossi ◽

L. Crinò ◽

A. Misino ◽

P. Bidoli ◽

A. Delmonte ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Efficacy And Safety ◽

Small Cell Lung ◽

Expanded Access ◽

Expanded Access Programme ◽

Access Programme

Download Full-text

P-587 Experience from a large multi-centre expanded access programme (EAP) with gefitinib (‘Iressa’, ZD1839) as monotherapy in advanced non-small cell lung cancer (NSCLC)

Lung Cancer ◽

10.1016/s0169-5002(05)81080-3 ◽

2005 ◽

Vol 49 ◽

pp. S272-S273

Author(s):

R. van Puijenbroek ◽

L. Bosquée ◽

G. Tits ◽

P. Germonpre ◽

E. Strobbe ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Expanded Access ◽

Expanded Access Programme ◽

Access Programme

Download Full-text

Survival outcomes in patients with advanced non-small cell lung cancer treated with erlotinib: expanded access programme data from Belgium (the TRUST study)

European Journal of Cancer Care ◽

10.1111/ecc.12146 ◽

2013 ◽

Vol 23 (3) ◽

pp. 370-379 ◽

Cited By ~ 5

Author(s):

J. Van Meerbeeck ◽

D. Galdermans ◽

F. Bustin ◽

L. De Vos ◽

I. Lechat ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Survival Outcomes ◽

Small Cell Lung ◽

Expanded Access ◽

Expanded Access Programme ◽

Access Programme

Download Full-text

Use of nivolumab in elderly patients with advanced squamous non–small-cell lung cancer: results from the Italian cohort of an expanded access programme

European Journal of Cancer ◽

10.1016/j.ejca.2018.05.015 ◽

2018 ◽

Vol 100 ◽

pp. 126-134 ◽

Cited By ~ 36

Author(s):

Francesco Grossi ◽

Lucio Crinò ◽

Antonio Logroscino ◽

Stefania Canova ◽

Angelo Delmonte ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Expanded Access ◽

Expanded Access Programme ◽

Access Programme ◽

Italian Cohort

Download Full-text

Faculty Opinions recommendation of Use of nivolumab in elderly patients with advanced squamous non-small-cell lung cancer: results from the Italian cohort of an expanded access programme.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.733652114.793548529 ◽

2018 ◽

Author(s):

Alexandru Grigorescu

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Expanded Access ◽

Expanded Access Programme ◽

Access Programme ◽

Italian Cohort

Download Full-text

P3-139: Evaluation of safety and efficacy of Erlotinib (Tarceva) as monotherapy in a series of Chinese patients with advanced non–small–cell lung cancer: preliminary experience from an expanded access programme

Journal of Thoracic Oncology ◽

10.1097/01.jto.0000284114.49329.4b ◽

2007 ◽

Vol 2 (8) ◽

pp. S738-S739

Author(s):

Yuankai Shi ◽

Xiaohui He ◽

Lin Gui ◽

Sheng Yang

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Chinese Patients ◽

Small Cell Lung ◽

Safety And Efficacy ◽

Expanded Access ◽

Expanded Access Programme ◽

Access Programme

Download Full-text

Faculty Opinions recommendation of Use of nivolumab in elderly patients with advanced squamous non-small-cell lung cancer: results from the Italian cohort of an expanded access programme.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.733652114.793574726 ◽

2020 ◽

Author(s):

Maria-José Molina-Garrido

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Expanded Access ◽

Expanded Access Programme ◽

Access Programme ◽

Italian Cohort

Download Full-text

Lessons from the ‘Iressa’ Expanded Access Programme: gefitinib in special non-small-cell lung cancer patient populations

British Journal of Cancer ◽

10.1038/sj.bjc.6601479 ◽

2003 ◽

Vol 89 (S2) ◽

pp. S19-S23 ◽

Cited By ~ 15

Author(s):

R Stahel ◽

A Rossi ◽

L Petruzelka ◽

P Kosimidis ◽

F de Braud ◽

...

Keyword(s):

Lung Cancer ◽

Cancer Patient ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Lung Cancer Patient ◽

Small Cell ◽

Small Cell Lung ◽

Expanded Access ◽

Expanded Access Programme ◽

Access Programme

Download Full-text

798 Impact of third line ZD 1839 therapy on patients with advanced non-small cell lung cancer (NSCLC) who had failed prior platinum and/or docetaxel-based regimens (Astra Zeneca Expanded Access Programme)

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(03)90823-8 ◽

2003 ◽

Vol 1 (5) ◽

pp. S240

Author(s):

F. De Marinis ◽

A. Mancuso ◽

O. Martelli ◽

M.R. Migliorino ◽

R. Di Salvia

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Expanded Access ◽

Expanded Access Programme ◽

Access Programme ◽

Third Line

Download Full-text

Italian nivolumab expanded access programme: real-world results in non-squamous non-small cell lung cancer patients

Annals of Oncology ◽

10.1093/annonc/mdx376.021 ◽

2017 ◽

Vol 28 ◽

pp. v410-v411 ◽

Cited By ~ 2

Author(s):

F. Grossi ◽

L. Crinò ◽

A. Delmonte ◽

D. Turci ◽

G. Lo Russo ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Real World ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Expanded Access Programme ◽

Access Programme

Download Full-text